Cancer patients in Lebanon struggle for survival

Lebanese small business owner Ahmad Fahess thought nothing could be more devastating than his cancer diagnosis until suddenly, while he was at work one day, Israeli airstrikes started targeting his town of Nabatieh in south Lebanon.

When he saw the tangled mess around him, he knew he had to grab his family and flee. “We want to go back to our homes, to our work,” he said, breaking into tears as he received cancer treatment at the American University of Beirut’s Medical Center (AUBMC), his sister sitting next to his bed.

A father of two teenagers who owned four welding shops in Nabatieh, Fahess is now not only unsure when he will be able to go home, but also how long he will be able to access treatment for the rare cancer, sarcoma, which affects the connective tissue in his left arm.

“I used to come three days to Beirut for treatment and go back home,” he said. “Now with the war, we were displaced, and the treatment struggle started.” Thousands of cancer patients are among more than a million people who have fled their homes. “It all happened very quickly. We were at work when the shelling started; we were surprised by it,” he said. He fled with his family to Antelias in Mount Lebanon with only $4,500 that quickly dwindled.

Fahess now depends on the hospital’s Cancer Support Fund, a charity initiative launched in 2018 to assist cancer patients and now also giving extra support to displaced individuals. “The treatment is costly; if the hospital didn’t help me, I couldn’t have afforded it,” he said. But he is worried about funding drying up. “If we have to pay and we’re back at our homes, it would be fine, but if we are still displaced, it’ll be impossible,” he said.

Lebanon’s health ministry said more than 2,500 displaced cancer patients have been forced to find new treatment centres, as at least eight hospitals in southern Lebanon and Beirut’s southern suburbs were out of action due to Israeli shelling.

Ghazaleh Naddaf, 67, was displaced from the southern village of Debel. Now living with her brother in Beirut, the former pharmacist assistant lost her job and has been unable to afford her therapy for multiple myeloma for two months.

“I am skipping treatment and medication,” she said. “I used to come twice a week for treatment, paying over $1,000. I can’t afford it anymore,” adding that she also needs a bone marrow transplant costing $50,000, an expense far beyond her reach.

Reuters